Table 1 Baseline characteristics—Oxycodone Study.
Oxycodone Study | Ketamine Study | |||
|---|---|---|---|---|
Demographic variable | Safety population N = 50 | Completer population N = 47 | Safety population N = 54 | Completer population N = 51 |
Age, yearsa | 36.3 ± 8.9 | 36.3 ± 9.1 | 34.4 ± 9.8 | 34.4 ± 9.8 |
Male, n (%) | 40 (80.0) | 37 (78.7) | 37 (68.5) | 35 (68.6) |
Race, n (%) | ||||
White | 21 (42.0) | 20 (42.6) | 34 (63.0) | 32 (62.7) |
Black | 28 (56.0) | 27 (57.4) | 15 (27.8) | 14 (27.5) |
American Indian or Alaskan Native | 1 (2.0) | 0 | 2 (3.7) | 2 (3.9) |
Asian | 0 | 0 | 2 (3.7) | 2 (3.9) |
Other | 0 | 0 | 2 (3.7) | 2 (3.9) |
Hispanic or Latino, n (%) | 6 (12.0) | 5 (10.6) | 4 (7.4) | 4 (7.8) |
Body mass index, kg/m2 a | 26.8 ± 4.2 | 26.8 ± 4.2 | 25.2 ± 3.8 | 25.2 ± 3.7 |
